Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Emcure Pharma Expands Its Dermatology Portfolio

Emcure Pharma launches new dermatology-focused arm Emcutix Biopharma

Ruchika Sharma28 Oct 2024 4:14 PM IST

Pune: Emcure Pharmaceuticals Limited, an Indian Pharma company, has launched a wholly-owned subsidiary, Emcutix Biopharmaceuticals...

Piramal Pharma deploying USD 85 million capex this fiscal: Nandini Piramal

Ruchika Sharma28 Oct 2024 2:15 PM IST

New Delhi: A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, including...

Sun Pharma presents Leqselvi data highlighting clinical efficacy, durability for Alopecia Areata treatment at 2024 Fall Clinical Dermatology Conference

Ruchika Sharma28 Oct 2024 11:30 AM IST

Mumbai: Sun Pharmaceutical Industries Limited has presented new data highlighting the clinical efficacy and safety of LEQSELVI (deuruxolitinib) 8...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

MSD Phase 3 trial of head and neck cancer treatment meets primary endpoint

Ruchika Sharma13 Oct 2024 10:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA...

Shilpa Medicare arm, PPI to form new JV company in Saudi Arabia

Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India

Ruchika Sharma12 Oct 2024 11:00 AM IST

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and...

Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 years

Are certain Hair Loss drugs causing suicidal thoughts? EU drugs regulator begins review

Ruchika Sharma11 Oct 2024 2:00 PM IST

European Medicines Agency (EMA) has started a review of medicines containing finasteride and dutasteride. These medications are used to treat...

Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopenia

Switzerland COMCO competition commission terminates Novartis probe without consequences

Ruchika Sharma11 Oct 2024 12:30 PM IST

Berlin: Switzerland's COMCO competition commission said on Thursday that it has terminated a probe against Novartis into possibly using blocking...

Govt extends deadline for submitting applications under PLI Scheme

Akums unveils Dual-Action Heartburn Relief Chewable Tablets for India

Ruchika Sharma11 Oct 2024 11:30 AM IST

New Delhi: Akums Drugs and Pharmaceuticals has introduced dual-action heartburn relief chewable tablet, combining Famotidine, Calcium Carbonate, and...

EU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccine

Ruchika Sharma11 Oct 2024 10:00 AM IST

Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that the European...

GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits

Ruchika Sharma10 Oct 2024 6:17 PM IST

New York: Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S. state courts,...

Amneal Pharma to build two new manufacturing facilities in Ahmedabad

Ruchika Sharma10 Oct 2024 2:27 PM IST

New Delhi: US- based Amneal Pharmaceuticals to build two new manufacturing facilities in Ahmedabad with an investment of up to USD 200...

AbbVie to buy Gilgamesh Pharma Bretisilocin for Major Depressive Disorder

JnJ completes acquisition of V Wave

Ruchika Sharma10 Oct 2024 12:34 PM IST

New Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of V-Wave Ltd., a privately-held company...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok